Bayer (BAYN GY) gets Supreme Court review in bid to stop roundup suits, according to reports

Bayer's request for a Supreme Court review regarding the lawsuits tied to Roundup could signal a pivotal moment for the company as it seeks to mitigate its legal risks.

Newsquawk StaffPublished On the live feed at 1 more headline followed before this page went public
Newsquawk headlinesUTC

IAEA says secured agreement between Russia and Ukraine to implement ceasefire for repairs to begin on last remaining backup power line to Zaporizhzhya plant

CRUDE WRAP: WTI (G6) SETTLES USD 0.25 HIGHER AT USD 59.44/BBL; BRENT (H6) SETTLES USD 0.37 HIGHER AT USD 64.13/BBL

Bayer (BAYN GY) gets Supreme Court review in bid to stop roundup suits, according to reports

Shell (SHEL) and Mitsubishi exploring potential sale of stakes in LNG assets

Genmab (GMAB) announces topline results for epcoritamab from Phase 3 Epcore dlbcl-1 trial in patients with relapsed/refractory diffuse; said study OS did not reach statistical significance; study demonstrated an overall survival of hr: 0.96

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This move may influence investor sentiment, particularly if it is perceived as a step towards resolution; any favorable outcome could alleviate some of the litigation pressures affecting its share price. Additionally, the implications for Bayer's financials and future M&A activities should be closely monitored as this case unfolds.

Related headlines

The whole workspace, free to try.

Try it free